株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

欧州の造影剤および放射性医薬品市場分析:2019年

Contrast Agents and Radiopharmaceuticals | Europe | 2019 | Market Analysis

発行 Millennium Research Group - DRG 商品コード 339435
出版日 ページ情報 英文 108 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
欧州の造影剤および放射性医薬品市場分析:2019年 Contrast Agents and Radiopharmaceuticals | Europe | 2019 | Market Analysis
出版日: 2018年07月23日 ページ情報: 英文 108 Pages
概要

償還規制が厳しくGBCAを取り巻く安全性に関する議論が続く中、欧州の造影剤および放射性医薬品市場は、放射性医薬品分野で平均販売価格が上昇すること、および人口の高齢化などの要因により、2027年まで緩やかに成長すると予測されています。

当レポートでは、欧州の造影剤および放射性医薬品市場の現状と今後10年の予測とともに、セグメント別市場の競合動向、市場シェアなどをまとめています。

第1章 造影剤および放射性医薬品市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア
  • 市場発展
  • 競合因子と戦略

第2章 放射性医薬品市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
    • SPECT
    • PET
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア
  • 競合因子と戦略

第3章 CTおよびX線造影剤市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
    • CT
    • 心血管用X線
    • 一般的X線
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア
  • 競合因子と戦略

第4章 MRI造影剤市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア
  • 競合因子と戦略

第5章 超音波造影剤市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア
  • 競合因子と戦略

調査方法

付録

目次
Product Code: M360RP0009

Despite stringent reimbursement regulations and the ongoing safety controversy surrounding GBCAs, the European contrast agent and radiopharmaceutical market will exhibit slight growth through 2027, propelled by ASP hikes in the radiopharmaceutical space and the increasing demand for diagnostic imaging procedures for Europe's aging population.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in Europe across a 10-year period.

Recent studies have questioned the safety of GBCAs

  • How has the EMA responded to studies that call into question the safety of GBCAs?
  • To what extent will these studies impact the MRI contrast agent market through 2027?
  • How can competitors best respond to these safety concerns such that the impact on their products and revenues can be minimized?

Global fluctuations in the supply of Mo-99-the key isotope in the production of Tc for use in most SPECT procedures-will continue to negatively impact the market going forward

  • To what extent will supply limitations affect revenue growth in the European SPECT radiopharmaceutical market?

Less contrast material is being used per patient procedure in Europe

  • What are some of the key factors driving this trend?
  • What novel technology will contribute to this trend in the future?
  • Which markets will be the most impacted by this shift in usage?

The European market is more competitive compared to the US market

  • What are the key factors end users look for in a product?
  • How do local competitors fare compared to MNCs in the European contrast agent and radiopharmaceutical market?
  • How can smaller companies best position themselves to garner more market share going forward?

Table of Contents

Table of Contents

Tables and Figures

Executive Summary

Version History.

1 Contrast Agent and Radiopharmaceutical Market

  • 1.1 Market Highlights
  • 1.2 Market Definitions
  • 1.3 Market Forecast Data
  • 1.4 General Market Trends
  • 1.5 Competitive Highlights
  • 1.6 Market Shares
  • 1.7 Market Developments
  • 1.8 Competitive Factors and Strategies

2 Radiopharmaceutical Market

  • 2.1 Market Highlights
  • 2.2 Market Definitions
  • 2.3 Market Forecast Data
    • 2.3.1 SPECT Radiopharmaceuticals
    • 2.3.2 PET Radiopharmaceuticals
  • 2.4 General Market Trends
  • 2.5 Competitive Highlights
  • 2.6 Market Shares
  • 2.7 Competitive Factors and Strategies

3 CT and X-Ray Contrast Agent Market

  • 3.1 Market Highlights
  • 3.2 Market Definitions
  • 3.3 Market Forecast Data
    • 3.3.1 Computed Tomography
    • 3.3.2 Cardiovascular X-Ray
    • 3.3.3 Conventional X-Ray
  • 3.4 General Market Trends
  • 3.5 Competitive Highlights
  • 3.6 Market Shares
  • 3.7 Competitive Factors and Strategies

4 MRI Contrast Agent Market

  • 4.1 Market Highlights
  • 4.2 Market Definitions
  • 4.3 Market Forecast Data
  • 4.4 General Market Trends
  • 4.5 Competitive Highlights
  • 4.6 Market Shares
  • 4.7 Competitive Factors and Strategies

5 Ultrasound Contrast Agent Market

  • 5.1 Market Highlights
  • 5.2 Market Definitions
  • 5.3 Market Forecast Data
  • 5.4 General Market Trends
  • 5.5 Competitive Highlights
  • 5.6 Market Share Rankings
  • 5.7 Competitive Factors and Strategies

Methodology

  • Core Country Coverage Methodology
  • Supplemental Country Coverage Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

  • Table 1: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe
  • Figure 1: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2017-2027
  • Table 2: Contrast Agent and Radiopharmaceutical Market Landscape, Europe (USD), 2018 and 2027
  • Table 3: Competitive Factors and Strategies, by Product Type, Europe
  • Table 4: Contrast Agent and Radiopharmaceutical Procedure Market Share Rankings, by Product Type, Europe, 2018
  • Table 5: Companies Mentioned
  • Table 6: Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
  • Table 7: Geographies Covered, Europe
  • Table 8: Average Currency Exchange Rates
  • Table 9: Contrast Agents and Radiopharmaceutical Procedures and Products Covered, Europe
  • Table 10: Version History
  • Table 11: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe
  • Figure 2: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2017-2027
  • Figure 3: Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD), 2017-2027
  • Table 12: Contrast Agent and Radiopharmaceutical Procedures, by Product Type, Europe, 2017-2027
  • Table 13: Contrast Agent and Radiopharmaceutical Procedures, by Country, Europe, 2017-2027
  • Table 14: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD and EUR), 2017-2027
  • Table 15: Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD, EUR, and GBP), 2017-2027
  • Figure 4: Contrast Agent and Radiopharmaceutical Procedure Market Shares, Europe, 2018
  • Table 16: Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2018
  • Table 17: Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Product Type, Europe, 2018
  • Table 18: Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
  • Table 19: Competitive Factors and Strategies, by Product Type, Europe
  • Figure 5: Radiopharmaceutical Market, by Product Type, Europe (USD), 2017-2027
  • Figure 6: Radiopharmaceutical Market, by Country, Europe (USD), 2017-2027
  • Table 20: Radiopharmaceutical Market, by Product Type, Europe (USD), 2017-2027.
  • Table 21: Radiopharmaceutical Market, by Product Type, Europe (EUR), 2017-2027
  • Table 22: Radiopharmaceutical Market Growth, by Product Type, Europe, 2018-2027
  • Table 23: Radiopharmaceutical Market, by Country, Europe (USD), 2017-2027
  • Table 24: Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 25: Radiopharmaceutical Market Growth, by Country, Europe, 2018-2027
  • Table 26: Nuclear Medicine System Installed Base, by Product Type, Europe, 2017-2027
  • Table 27: Nuclear Medicine System Ins talled Base, by Country, Europe, 2017-2027
  • Table 28: SPECT Radiopharmaceutical Market, by Country, Europe (USD), 2017-2027
  • Table 29: SPECT Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 30: SPECT Radiopharmaceutical Market Growth, by Country, Europe, 2018-2027
  • Table 31: SPECT Radiopharmaceutical Installed Base, by Country, Europe, 2017-2027
  • Table 32: PET Radiopharmaceutical Market, by Country, Europe (USD), 2017-2027
  • Table 33: PET Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 34: PET Radiopharmaceutical Market Growth, by Country, Europe, 2018-2027
  • Table 35: PET Radiopharmaceutical Installed Base, by Country, Europe, 2017-2027
  • Figure 7: SPECT Radiopharmaceutical Procedure Market Shares, Europe, 2018
  • Table 36: SPECT Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2018
  • Table 37: Competitive Factors and Strategies, Europe
  • Figure 8: CT and X-Ray Contrast Agent Market, by Product Type, Europe (USD), 2017-2027
  • Figure 9: CT and X-Ray Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 38: CT and X-Ray Contrast Agent Market, by Product Type, Europe (USD), 2017-2027
  • Table 39: CT and X-Ray Contrast Agent Market, by Product Type, Europe (EUR), 2017-2027
  • Table 40: CT and X-Ray Contrast Agent Market Growth, by Product Type, Europe, 2018-2027
  • Table 41: CT and X-Ray System Installed Base, by Country, Europe, 2017-2027.
  • Table 42: CT and X-Ray Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 43: CT and X-Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 44: CT and X-Ray Contrast Agent Market Growth, by Country, Europe, 2018- 2027
  • Table 45: CT System Ins talled Base, by Country, Europe, 2017-2027
  • Table 46: X-Ray System Installed Base, by Country, Europe, 2017-2027
  • Table 47: CT Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 48: CT Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 49: CT Contrast Agent Market Growth, by Country, Europe, 2018-2027
  • Table 50: Cardiovascular X-Ray Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 51: Cardiovascular X-Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 52: Cardiovascular X-Ray Contrast Agent Market Growth, by Country, Europe, 2018-2027
  • Table 53: Conventional X-Ray Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 54: Conventional X-Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 55: Conventional X-Ray Contrast Agent Market Growth, by Country, Europe, 2018-2027
  • Figure 10: CT and X-Ray Contrast Agent Procedure Market Shares, Europe, 2018
  • Table 56: CT and X-Ray Contrast Agent Procedure Market Shares, by Country, Europe, 2018
  • Table 57: Competitive Factors and Strategies, Europe
  • Figure 11: MRI Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 58: MRI Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 59: MRI Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 60: MRI Contrast Agent Market Growth, by Country, Europe, 2018-2027
  • Table 61: MRI System Installed Base, by Country, Europe, 2017-2027.
  • Figure 12: MRI Contrast Agent Procedure Market Shares, Europe, 2018
  • Table 62: MRI Contrast Agent Procedure Market Shares, by Country, Europe, 2018
  • Table 63: Competitive Factors and Strategies, Europe
  • Figure 13: Ultrasound Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 64: Ultrasound Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 65: Ultrasound Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 66: Ultrasound Contrast Agent Market Growth, by Country, Europe, 2018-2027
  • Table 67: Ultrasound Contrast Agent Revenue Market Share Rankings, Europe, 2018
  • Table 68: Competitive Factors and Strategies, Europe.
  • Table 69: Acronyms and Initialisms
Back to Top